CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 8 No. 6
 

Medicare Reform Compromise Fell Victim to Complex Politics

June 1, 1999

ALEXANDRIA, Va—The failure of the National Bipartisan Commission on the Future of Medicare to issue a report resulted from complex political calculations made by various players in the process. “Behind the political differences lies a legitimate difference on the role of the government in health care,” Washington attorney John S. Hoff said at the 25th Annual Meeting of the Association of Community Cancer Centers (ACCC).

The Commission and its “non-report” nonetheless constitute “the first step in something that will happen anyway,” he said, ie, movement toward a reimbursement system that better fits the demographic, medical, and fiscal realities of the nation in the coming decades.

The 17-member Commission missed by one vote achieving the supermajority of 11 needed to report out a proposal that would have combined elements of liberal plans to give the government more power to contract for Medicare services with selected providers with elements of conservative plans to provide beneficiaries a fixed sum to buy their own private health insurance.

Based on the Federal Employee Health Benefit Plan, it would have raised the age of eligibility, made drug coverage available for everyone, provided free drugs for the poor, and combined Medicare Parts A and B for funding and deductibles. As a premium support plan, it would have maintained the basic commitment of the traditional Medicare defined-benefit plan in a more efficient system.

Solvency of Parts A and B

Originally feared to be depleted in 2002, the Hospital Insurance Trust Fund that supports Medicare Part A was made solvent until 2008 by cutting reimbursements for hospital costs, limiting home health care, and transferring part of home health care to Part B. Part B, however, is an “open draw on general revenues,” Mr. Hoff said.

The real issue, he said, is total spending, not the solvency of the Trust Fund. By the year 2030, the present system, which now costs $247 billion a year, would cost between $2.2 and $2.9 trillion, or between 28% and 38% of the federal budget and between 6.3% and 8.5% of the gross domestic product.

Medicare, if unchanged, he said, will consume two to three times as great a share of resources as it does now, while providing benefits that are already outdated because they do not cover long-term care and outpatient drugs.

When established, Medicare provided “open-ended payment for anything doctors ordered,” Mr. Hoff said. Attempts to control spending over the years have produced today’s “complex of fixed prices.” Many people now support using market competition rather than price controls to increase efficiency, and favor government-funded private insurance in place of government control of the system.

“The premium support plan voted on by the Commission would have reduced the current rate of spending growth by 12%,” Mr. Hoff said. It received the support of all the Commission’s eight Republicans and two of its nine Democrats.

“The plan failed in large part because the White House signaled that it had a different plan,” Mr. Hoff said. In his State of the Union message, Clinton announced a plan to save Medicare by applying 15% of the budget surplus. “Although this only bails out Part A for a few years and does nothing to control cost,” Mr. Hoff said, “the public thought it would solve the overall problem.”

When Clinton’s idea was criticized, the President said he would not comment until he received the Commission report. Then, 2 hours before the Commission voted, he declared that the Commission’s plan did not meet his principles and said he would produce his own plan later this year. “The Senate Finance Committee will likely report out a Medicare bill this year,” Mr. Hoff said, adding, however, that passage by Congress is unlikely.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy